The Joint Corp. (NASDAQ:JYNT – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 487,300 shares, a decline of 7.7% from the October 15th total of 528,100 shares. Based on an average daily trading volume, of 48,800 shares, the short-interest ratio is presently 10.0 days.
Wall Street Analysts Forecast Growth
JYNT has been the subject of a number of recent analyst reports. StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a report on Friday. Roth Mkm decreased their price objective on shares of Joint from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, November 8th.
Get Our Latest Research Report on JYNT
Institutional Investors Weigh In On Joint
Joint Stock Performance
JYNT stock opened at $10.80 on Tuesday. The company has a market capitalization of $161.83 million, a price-to-earnings ratio of -9.70 and a beta of 1.57. The business’s 50 day moving average price is $11.31 and its two-hundred day moving average price is $12.95. Joint has a fifty-two week low of $8.38 and a fifty-two week high of $17.82.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Further Reading
- Five stocks we like better than Joint
- How to Find Undervalued Stocks
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is a Stock Market Index and How Do You Use Them?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Upcoming IPO Stock Lockup Period, Explained
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.